Table 1 Demographic and clinical characteristics in patients with and without statin prescription.*
From: Patterns and predictors of statin prescription in patients with type 2 diabetes
Characteristic | Statin prescription | No statin prescription |
|---|---|---|
Number, (%) | 13,150 (25.5%) | 38,490 (74.5%) |
Men (%) | 27.6 | 72.4 |
Women (%) | 23.4 | 76.6 |
Age (years) | 65.6 ± 9.5 | 65.1 ± 11.3 |
Age at diagnosis of diabetes (years) | 58.3 ± 10.2 | 58.5 ± 11.2 |
Diabetes duration (years) | 7.3 ± 6.4 | 6.6 ± 6.1 |
Body mass index (kg/m2) | 28.9 ± 4.4 | 28.9 ± 4.9 |
Smoking status | ||
Never smoker (%) | 23.6 | 76.4 |
Former smoker (%) | 31.5 | 68.5 |
Current smoker (%) | 24.4 | 75.6 |
Hypertension (%) | 86.4 | 13.6 |
Systolic blood pressure (mmHg) | 143 ± 17 | 143 ± 18 |
Diastolic blood pressure (mmHg) | 83 ± 10 | 83 ± 10 |
Microalbuminuria (%) | 42.3 | 57.7 |
Creatinine (mg/dl) | 1.35 ± 2.51 | 1.31 ± 2.45 |
Estimated glomerular filtration rate (ml/min) | 74 ± 36 | 76 ± 37 |
HbA1c (%) | 7.3 ± 1.3 | 7.3 ± 1.3 |
Fasting plasma glucose (mg/dl) | 147 ± 46 | 148 ± 48 |
Lipoprotein concentrations | ||
Total cholesterol (mg/dl) | 221 ± 53 | 226 ± 50 |
LDL cholesterol (mg/dl) | 131 ± 40 | 138 ± 38 |
HDL cholesterol (mg/dl) | 48 ± 13 | 49 ± 14 |
Triglycerides (mg/dl) | 226 ± 260 | 218 ± 313 |
Estimated 5-year cardiovascular risk (primary prevention) | 18.3 ± 10.6 | 14.5 ± 10.1 |
Atherosclerotic complications | ||
Coronary heart disease (%) | 43.5 | 56.5 |
Cerebrovascular disease (%) | 11.0 | 89.0 |
Peripheral art. occlusive dis. (%) | 15.5 | 84.5 |